Innate Pharma S.A. (IPHA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | -2.07M | 4.86M | 276K | 12.35M | 16.56M | 35.34M | 8.31M | 41.27M | 2.79M | 9.32M | 26.99M | 36.74M |
| Revenue Growth % | -851.09% | -60.63% | -98.33% | -65.07% | 99.27% | -14.36% | 197.49% | 342.87% | -89.65% | -74.64% | 55.25% | -28.77% |
| Cost of Goods Sold | 0 | 20.52M | -29.08M | 29.08M | 24.57M | 15.73M | 13.35M | 12.48M | 12.9M | 10.6M | 4.65M | 31.5M |
| COGS % of Revenue | - | 422.22% | -10534.78% | 235.53% | 148.39% | 44.5% | 160.71% | 30.23% | 461.8% | 113.79% | 17.23% | 85.72% |
| Gross Profit | 18.45M | -15.66M | 29.35M | -16.73M | -3.13M | 19.62M | -5.04M | 28.79M | -10.11M | -1.28M | 22.34M | 5.25M |
| Gross Margin % | -889.87% | -322.22% | 10634.78% | -135.53% | -18.88% | 55.5% | -60.71% | 69.77% | -361.8% | -13.79% | 82.77% | 14.28% |
| Gross Profit Growth % | -37.15% | 6.4% | 1038.96% | -185.29% | 38.03% | -31.87% | 50.08% | 2340.7% | -145.23% | -124.49% | 83.07% | -84.24% |
| Operating Expenses | 46.45M | 9.77M | 54.61M | 9.58M | 9.14M | 36.95M | 34.73M | 35.05M | 31.32M | 33.71M | 37.84M | 13.59M |
| OpEx % of Revenue | -2240.47% | 200.97% | 19787.68% | 77.62% | 55.23% | 104.55% | 417.99% | 84.94% | 1121.27% | 361.69% | 140.19% | 37% |
| Selling, General & Admin | 1.23M | 9.77M | 2.35M | 9.58M | 9.14M | 8.54M | 9.57M | 11.37M | 5.51M | 13.38M | 16.05M | 14.49M |
| SG&A % of Revenue | -59.43% | 200.97% | 851.81% | 77.62% | 55.23% | 24.17% | 115.15% | 27.55% | 197.14% | 143.63% | 59.47% | 39.43% |
| Research & Development | 22.93M | 20.52M | 22.9M | 29.08M | 24.57M | 28.41M | 25.16M | 23.68M | 25.81M | 20.32M | 21.79M | 31.5M |
| R&D % of Revenue | -1106.08% | 422.22% | 8298.55% | 235.53% | 148.39% | 80.38% | 302.84% | 57.38% | 924.13% | 218.06% | 80.72% | 85.72% |
| Other Operating Expenses | 1000K | -1000K | 1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Operating Income | -28M | -25.43M | -25.26M | -26.31M | -7.42M | -5.25M | -28.8M | 4.17M | -30.9M | -26.58M | -17.41M | -8.35M |
| Operating Margin % | 1350.6% | -523.19% | -9152.9% | -213.15% | -44.79% | -14.86% | -346.66% | 10.12% | -1106.37% | -285.21% | -64.51% | -22.72% |
| Operating Income Growth % | -10.83% | 3.37% | -240.64% | -400.91% | 74.25% | -225.82% | 6.79% | 115.71% | -77.47% | -218.39% | 58% | -246.23% |
| EBITDA | -27.33M | -25.06M | -24.02M | -25.56M | -5.54M | -1.61M | -26.42M | 6.22M | -28.52M | -24.39M | -10.85M | -1.63M |
| EBITDA Margin % | 1318.19% | -515.66% | -8702.17% | -207.07% | -33.47% | -4.55% | -317.99% | 15.06% | -1021.27% | -261.69% | -40.19% | -4.43% |
| EBITDA Growth % | -13.77% | 1.96% | -333.38% | -1489.74% | 79.03% | -125.86% | 7.37% | 125.49% | -162.94% | -1397.05% | 65.83% | -113% |
| D&A (Non-Cash Add-back) | 671.99K | 366K | 1.24M | 750K | 1.87M | 3.65M | 2.38M | 2.04M | 2.38M | 2.19M | 6.56M | 6.72M |
| EBIT | -31.38M | -25.43M | -22.59M | -26.31M | -12.27M | -2.81M | -12.46M | 4.25M | -29.28M | -28.47M | -60.37M | -8.35M |
| Net Interest Income | 4.24M | 564K | 67K | 1.94M | 8.92M | 641K | 254K | 2K | 2K | 5.5K | 26.5K | 170K |
| Interest Income | 7.11M | 564K | 101K | 2.54M | 11.94M | 965K | 348K | 2K | 2K | 5.5K | 26.5K | 170K |
| Interest Expense | 2.87M | 0 | 34K | 600K | 3.02M | 324K | 94K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 165K | 4.08M | 555K | 1.55M | 2.98M | 2.12M | -39.31M | -2.14M | 1.48M | -2.07M | -43.12M | -1.99M |
| Pretax Income | -27.83M | -21.34M | -24.71M | -24.76M | -4.43M | -3.14M | -68.11M | 2.11M | -29.42M | -28.65M | -60.53M | -10.33M |
| Pretax Margin % | 1342.64% | -439.18% | -8951.81% | -200.6% | -26.78% | -8.87% | -819.75% | 5.1% | -1053.24% | -307.46% | -224.27% | -28.12% |
| Income Tax | -2.99M | 0 | 0 | 0 | 0 | -4.85M | -3.77M | -4.27M | -7.66M | -4.93M | -6.88M | 0 |
| Effective Tax Rate % | 10.76% | 0% | 0% | 0% | 0% | 154.78% | 5.53% | -202.75% | 26.03% | 17.22% | 11.37% | 0% |
| Net Income | -27.63M | -21.34M | -24.71M | -24.76M | -9.29M | 1.72M | -64.41M | 6.3M | -29.09M | -23.72M | -53.65M | -10.33M |
| Net Margin % | 1332.71% | -439.18% | -8951.81% | -200.6% | -56.1% | 4.86% | -775.14% | 15.27% | -1041.53% | -254.52% | -198.76% | -28.12% |
| Net Income Growth % | -11.82% | 13.81% | -166.01% | -1541.44% | 85.58% | -72.74% | -121.4% | 126.57% | 45.78% | -129.52% | -57.8% | -178.05% |
| Net Income (Continuing) | -27.63M | -21.34M | -24.71M | -24.76M | -9.29M | 1.72M | -64.35M | 6.38M | -21.76M | -23.72M | -53.65M | -10.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | -29K | -73K | -1000K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.30 | -0.25 | -0.30 | -0.31 | -0.12 | 0.02 | -0.80 | 0.08 | -0.37 | -0.30 | -0.68 | -0.13 |
| EPS Growth % | 0% | 19.35% | -150% | -1612.2% | 85% | -73.38% | -116.22% | 125.67% | 45.59% | -130.77% | -30.77% | -165% |
| EPS (Basic) | -0.30 | -0.25 | -0.30 | -0.31 | -0.12 | 0.02 | -0.80 | 0.08 | -0.37 | -0.30 | -0.68 | -0.13 |
| Diluted Shares Outstanding | 91.41M | 86.94M | 81.05M | 80.87M | 80.59M | 83.78M | 80.19M | 81.87M | 79.54M | 79M | 78.93M | 78.89M |
| Basic Shares Outstanding | 91.41M | 85.38M | 81.05M | 79.88M | 80.59M | 80.32M | 80.19M | 79.74M | 79.54M | 79M | 78.93M | 78.89M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |